Full Name
XXX Folefac Aminkeng
(not current staff)
Main Affiliation
 
 
Email
mdcfa@nus.edu.sg
 

Publications

Refined By:
Type:  Article
Date Issued:  [2020 TO 2024]
Subject:  Oncology

Results 1-4 of 4 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
112-May-2023Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang; Kee, Adrian; Tay, Sen Hee; Aminkeng, Folefac ; Ang, Yvonne; Wong, Alvin SC; Bharwani, Lavina D; Goh, Boon Cher; Soo, Ross A 
21-Mar-2021Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control StudyLee, Pei Yi; Oen, Kellynn Qi Xuan; Lim, Grace Rui Si; JUANDA LEO HARTONO ; MARK DHINESH MUTHIAH ; Huang, Daniel Q; Teo, Felicia Su Wei; LI YUNKAI ANDREW ; Mak, A. ; Chandran, Nisha Suyien; CHRIS TAN LIXIAN ; Yang, Peiling; Tai, E.S. ; Ng, Kay Wei Ping; JOY VIJAYAN ; Chan, Yee Cheun; TAN LI LING ; LEE BENG HUAT, MARTIN ; Chua, Horng Ruey; HONG WEI ZHEN ; YAP ENG SOO ; Lim, Dawn K; YUEN YEW SEN ; Chan, Y.H. ; FOLEFAC AMINKENG ; Wong, Alvin Seng Cheong; Huang, Yiqing; TAY SEN HEE 
330-Sep-2022Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang ; Wong, Alvin; Aminkeng, Folefac ; Ang, Yvonne; Asokumaran, Yugarajah; Low, Jia Li; Lee, Matilda; Choo, Joan RE; Chan, Gloria; Kee, Adrian ; Tay, Sen Hee ; Goh, Boon Cher ; Soo, Ross A 
413-Oct-2021Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patientsHuang, Yiqing; Soon, Yu Yang ; Aminkeng, Folefac ; Tay, Sen Hee ; Ang, Yvonne; Kee, Adrian CL ; Goh, Boon Cher ; Wong, Alvin SC; Soo, Ross A